UNC Neurology is proud to announce its designation as a GBS | CIDP Foundation International Center of Excellence for the diagnosis and treatment of Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy, and other inflammatory peripheral neuropathies. Designated centers demonstrate a consistently high level of patient care, expertise, treatments, facilities, and research capabilities. Rebecca Traub, MD, an associate professor in the Neuromuscular Division, led efforts to secure the designation.
Founded in 1980, GBS/CIDP Foundation International has 35,000 members worldwide and supports 44 global centers of excellence. The organization’s mission is to support those touched by GBS/CIDP and variants so that every patient has access to an early and accurate diagnosis, proper treatment, and the opportunity for a full recovery. Their leadership, guided by a board of directors, is committed to success in all areas of support, education, research and advocacy.